Improving Chemotherapy Tolerance in Breast Cancer (IMAGE)

Juntendo University Research Promotion Center

Improving Chemotherapy Tolerance in Breast Cancer

Caption

Researchers from Japan found that a 5 mg dose of olanzapine, taken after chemotherapy, significantly reduces nausea and vomiting in breast cancer patients, while minimizing sedation and cutting costs. This patient-centered approach could reshape global standards for antiemetic care.

Credit

Prof. Mitsue Saito from Juntendo University, Japan

Usage Restrictions

You are free to share and adapt the material. Attribution is required

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.